HALO Halozyme Therapeutics Inc

USD 57.29 -1.50 ( -2.55%)
Icon

Halozyme Therapeutics Inc (HALO) Financial Statements

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Slightly Bullish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 57.29

-1.50 (-2.55%)

USD 7.38B

1.27M

USD 69.77(+21.78%)

USD 47.80 (-16.56%)

Icon

HALO

Halozyme Therapeutics Inc (USD)
COMMON STOCK | NSD
USD 57.29
-1.50 ( -2.55%)

Halozyme Therapeutics Inc (HALO) Annual Income Statement (USD)

HALO Quarterly Financials (USD)

Frequently Asked Questions About Halozyme Therapeutics Inc (HALO) Stock

Halozyme Therapeutics Inc's (HALO) last reported annual revenue was USD 1.02 Billion.

Halozyme Therapeutics Inc's (HALO) annual revenue growth rate based on the revenue reported in the past 5 years is : 38.95%

Halozyme Therapeutics Inc's(HALO) is profitable as of its last reported annual financials.

The net profit margin for Halozyme Therapeutics Inc's(HALO) from its laster reported year is 43.74%

The return on equity (ROE) for Halozyme Therapeutics Inc's(HALO) from its last reported annual financials is : 198.42%

The return on assets (ROA) for Halozyme Therapeutics Inc's(HALO) from its last reported annual financials is : 18.16%

The return on invested capital (ROIC) for Halozyme Therapeutics Inc's(HALO) from its last reported annual financials is : 25.40%

The Debt to Equity ratio for Halozyme Therapeutics Inc's(HALO) from its last reported annual financials is : 413.88%

The dividend yield for Halozyme Therapeutics Inc's(HALO) from its laster reported year is 0.00%

Halozyme Therapeutics Inc's(HALO) has negative cash flow as of its last reported annual financials.

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...